News | March 20, 2025
Aerogen opens India HQ in New Delhi
The new office in New Delhi marks a significant funding in the APAC region and reinforces the company’s commitment to advancing respiratory care in India
The new office in New Delhi marks a significant funding in the APAC region and reinforces the company’s commitment to advancing respiratory care in India
Indegene combines deep healthcare expertise with a digital-first approach to help pharma, biotech and medical device companies commercialize their products
Experts urge early detection & better access to care
Empagliflozin is used in the treatment of type-2 diabetes mellitus, chronic kidney disease and heart failure
The new lenders – JP Morgan, HSBC, and Barclays provided fresh funding
Overall investment in the US facility is estimated around US$50 million
Zydus will carry out early-stage development, animal immunogenicity studies and regulatory preclinical toxicology studies for this combination vaccine
Amgen India investment totals $200 million through 2025
This innovative platform is strategically essential to developing and scaling high-value life sciences use cases such as streamlining the content supply chain
Cipla Limited has received final approval from the USFDA for the New Drug Application submitted for ‘Nilotinib Capsules 50, 150 and 200 mg’
Subscribe To Our Newsletter & Stay Updated
